Patents Assigned to SHANGHAI BLOOD CENTER
  • Patent number: 11013844
    Abstract: A device and method can be used for clinical virus inactivation treatment to automatically, continuously and cyclically treat plasma of a patient in a closed system. The disclosed plasma treatment device may be used for an anti-viral agent such as, for example, methylene blue photochemical plasma virus inactivation. The plasma treatment device can perform real-time treatment to the plasma in the closed system on the basis of the principle of plasma exchange and can realize real-time back-transfusion during treatment.
    Type: Grant
    Filed: November 19, 2015
    Date of Patent: May 25, 2021
    Assignees: City of Hope, Shanghai Blood Center
    Inventors: Yuwen Huang, Qin Mo, Bo Zhang, Kaicheng Qian, Yongming Zhu, Shirong Wang, Xun Wang, Xiaofei Wu, Yao Jia, Lidong Liu
  • Publication number: 20140221246
    Abstract: Disclosed are a human rare blood type detection method, a kit, a rapid screening method and applications thereof. By using multiple pairs of PCR specific primers directing to the SNP loci of multiple rare blood types, the SNP loci of multiple rare blood types are simultaneously detected in the same PCR reaction system; and the multiplex PCR detection method and a Pool detection method are combined to rapidly screen the human rare blood types.
    Type: Application
    Filed: January 18, 2012
    Publication date: August 7, 2014
    Applicant: SHANGHAI BLOOD CENTER
    Inventors: Luyi Ye, Ziyan Zhu, Zhonghui Guo, Tunlei He, Huanhuan Gao, Pan Wang, Li Xie, Aoxue Zhu, Wei Zhang, Wenji Gao, Qixiu Yang